Yüklüyor......
Molecular markers of prognosis and therapeutic targets in metastatic colorectal cancer
Metastatic disease ultimately occurs in approximately 50–70% of patients presenting with colorectal cancer. In patients with advanced disease, there is significant variability in individual patient outcomes. To improve understanding of tumor behavior, markers such as KRAS and BRAF mutation status ar...
Kaydedildi:
| Yayımlandı: | Surg Oncol |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2016
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5152574/ https://ncbi.nlm.nih.gov/pubmed/27566022 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.suronc.2016.05.018 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|